Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TNDM | Common Stock | Options Exercise | $71.4K | +797 | +184.92% | $89.54 | 1.23K | Dec 7, 2021 | Direct | F1 |
transaction | TNDM | Common Stock | Options Exercise | $23.5K | +286 | +23.29% | $82.34 | 1.51K | Dec 7, 2021 | Direct | F1 |
transaction | TNDM | Common Stock | Sale | -$152K | -1.08K | -71.53% | $140.00 | 431 | Dec 7, 2021 | Direct | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TNDM | Stock Option | Options Exercise | $71.4K | +797 | +3.85% | $89.54 | 21.5K | Dec 7, 2021 | Common Stock | 797 | $89.54 | Direct | F3, F4 |
transaction | TNDM | Stock Option | Options Exercise | $23.5K | +286 | +3.44% | $82.34 | 8.6K | Dec 7, 2021 | Common Stock | 286 | $82.34 | Direct | F4, F5 |
Id | Content |
---|---|
F1 | Represents shares of common stock received upon exercise of a stock option award. |
F2 | The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. |
F3 | The options vested as to twenty-five (25%) of the underlying shares on 2/18/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). |
F4 | The expiration date for these options is 10 years from the date of grant. |
F5 | The options vested as to twenty-five (25%) of the underlying shares on 5/27/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the 2013 Plan. |